Literature DB >> 9516079

Structure and function of the insulin-like growth factor I receptor.

L Sepp-Lorenzino1.   

Abstract

Insulin-like growth factors I and II (IGF-I, IGF-II) were originally identified as potent mitogens and as the mediators of growth hormone action. Besides being mitogenic, however, these polypeptide growth factors play a crucial role in cell survival, and contribute to transformation and to maintenance of the malignant phenotype. Here we will discuss signaling by the IGFs, focusing specifically on the structure and function of the IGF-I receptor and the domains of this receptor responsible for distinct IGF functions: mitogenesis, transformation, and protection from apoptosis. We will also compare the structural domains of the related but functionally distinct receptor for insulin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516079     DOI: 10.1023/a:1005955017615

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  21 in total

1.  Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.

Authors:  Xiaonan Hou; Fei Huang; Luciana F Macedo; Sean C Harrington; Karen A Reeves; Ann Greer; Friedrich Graf Finckenstein; Angela Brodie; Marco M Gottardis; Joan M Carboni; Paul Haluska
Journal:  Cancer Res       Date:  2011-10-31       Impact factor: 12.701

2.  Expression of IGFBP7 mRNA in corticotrophs in the anterior pituitary of adrenalectomized rats.

Authors:  Takashi Nakakura; Azusa Soda; Keisuke Unno; Masakazu Suzuki; Shigeyasu Tanaka
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

3.  Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-1 receptor abundance in hypophysectomized and castrated rats.

Authors:  M Phillip; G Maor; S Assa; A Silbergeld; Y Segev
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

4.  Role of FGFR2-signaling in the pathogenesis of acne.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2009-05

5.  RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.

Authors:  Ulrich Hermanto; Cong S Zong; Weiqun Li; Lu-Hai Wang
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis.

Authors:  Matthew R Ritter; Michael I Dorrell; Joseph Edmonds; Sheila Fallon Friedlander; Martin Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 7.  Function of the IGF-I receptor in breast cancer.

Authors:  E Surmacz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

8.  Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells.

Authors:  Kamal Yavari; Mohammad Taghikhani; Mohammad Ghannadi Maragheh; Seyed A Mesbah-Namin; Mohammad Hossein Babaei
Journal:  Int J Colorectal Dis       Date:  2009-08-11       Impact factor: 2.571

9.  Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor.

Authors:  Xianke Zeng; Hua Zhang; Annabell Oh; Yan Zhang; Douglas Yee
Journal:  Breast Cancer Res Treat       Date:  2011-08-18       Impact factor: 4.872

10.  Genetic variation in insulin-like growth factors and brain tumor risk.

Authors:  Stefan Lönn; Nathaniel Rothman; William R Shapiro; Howard A Fine; Robert G Selker; Peter M Black; Jay S Loeffler; Amy A Hutchinson; Peter D Inskip
Journal:  Neuro Oncol       Date:  2008-06-18       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.